Default company panoramic image

TACS Consumer Health

A disruptive, consumer healthcare provider of direct subscription access to prescription strength drugs without required MD oversight

  • Stage Prototype Ready
  • Industry Consumer Products
  • Location Livingston, NJ, USA
  • Currency USD
  • Founded January 2011

Company Summary

NJ early stage company with a $10-25B target annual market. TACS Consumer Healthcare can capture a majority of sales through successive pipeline launches using a patent-pending model enabling Rx to Non-Rx switches of drugs not normally able to be regulated as Over the Counter. Yr 1 National US target of $200MM with sales growing to $825MM by Yr 5 for the first drug only. Cumulative projected 10-year EBITDA of $500MM.


  • Default avatar
    Keith S. Lerner
    Founder & CEO

    Keith Lerner is a stand-out leader, driver and implementer of business innovation, strategically growing both established and new consumer packaged goods brands to new market share, revenue and profit highs. Keith has played a pivotal leadership role in developing share building brand campaigns, external innovation deals and improved operating processes for numerous iconic consumer brands. He has also led a variety of successful new brand la


  • Default avatar
    Covington & Burling LLP